Global panic over the impact of the H1N1 swine flu pandemic appears to be waning after it was revealed that the US and Germany have followed in France’s footsteps and begun cancelling vaccine orders.
The US Government has confirmed that it requires less than half the vaccine doses originally sought from Australia’s CSL Ltd and has cut down its vaccine order by 22 million doses to 14 million doses.
German health officials have also confirmed they have slashed their order of GlaxoSmithKline’s (GSK) vaccine, after it was advised that only one dose was required rather than the two-dose treatment originally planned for.
The moves follow in the footsteps of France, where earlier last week health officials declared that the 94 million doses of A(H1N1) vaccine originally bought at an estimated cost of €869m were no longer needed, as only five million people had been vaccinated since the programme was launched in October.
The French and German Governments are in negotiation with GSK over the exact amount of cancellations, a process the German Government has described as being conducted on “friendly terms”.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData